Video 10: Neoadj Io For Msi-H Stage Ii And Iii Colon Cancer In 2024

Should MSI be determined in all patients with stage II and III colon cancer patients?

Molecular Profiling in Stage II and III Colon Cancer

Neoadjuvant immunotherapy in MSI-high colorectal cancer

Neoadjuvant checkpoint inhibition with radiotherapy in MSI-H/dMMR rectal cancer

FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancer

Stages of Colon Cancer

Updates in adjuvant and neoadjuvant treatment for colon cancer

What is microsatellite instability or MSI?

Microsatellite instability in stage II and III colorectal cancer

Alexandros G. Sfakianakis

Current and future trends in immunotherapy for MSI-H colorectal cancer

The role of neoadjuvant immunotherapy in MSI-high gastric cancer

Intensified dosing of neoadjuvant Foxy-5 for colon cancer in the NeoFox trial

ES2201: neoadjuvant nivo/ipi with radiotherapy in MSI-H/dMMR rectal tumors

Treatment of stage II and stage III rectal cancer

Medical-Question

MMR by IHC vs MSI by PCR

Promega Corporation

Debate: MSI High Colon Cancer - Upfront Chemotherapy

Dr. Nixon on the Role of MSI in Cancer

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancer

Debate: MSI High Colon Cancer - Immunotherapy

ASCO 2023 Expert Report on novelties in the treatment of colorectal cancer by S. Stintzing

European Society for Medical Oncology (ESMO)